World's first inactivated Sabin polio vaccine approved by China FDA

China's FDA has awarded marketing approval of the world's first Sabin strain inactivated polio vaccine, marking a milestone as well for the Institute of Medical Biology of the Academy of Medical Sciences.

The institute independently developed the strain but tapped the assistance of the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), Japan's National Institute of Infectious Diseases (NIID), the European Medicines Agency (EMA) and the U.K. in the review process, CFDA said.

China intends to provide the vaccine to developing countries through WHO's polio eradication program.

- here's the announcement from the CFDA (in Chinese)

Suggested Articles

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Moderna is entering an important time, its CEO says. And the company is doing so with a new finance chief from Big Biotech.

A new NEJM study found taking hydroxychloroquine after COVID-19 exposure doesn't reduce the risk of an infection. But questions remain.